New Kilo-HP Workshop at ICROM

摘要

As it is widely known and reported by several clinical trials surveys, oncology keeps on being by far the most significat therapeutic area of interest for new drug developments, with an increasing trend over the last ten years. Anticancer drugs are expected to account up to 35% of the total pharmaceutical pipeline in 2019 (source-Pharmarorbiects~R) with a high level of interest specifically in the anticancer immunological category.